Exicure, Inc. , today announced that on January 19, 2025, Exicure Inc. ("the Company") entered into a Share Purchase Agreement with GPCR Therapeutics Inc., a Korean corporation ("GPCR"), pursuant to ...
Immutep (IMMP) announces that patient enrolment has been completed in the investigator-initiated EFTISARC-NEO trial. EFTISARC-NEO is evaluating ...
News Medical on MSN4h
Insilico Medicine doses first patient in Phase I Trial of ISM6331 for mesotheliomaInsilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...
Received supportive FDA feedback on key elements of the potential ELI-002 Phase 3 study design, including dose, schedule, patient population and ...
Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...
((SL Advertiser)) Cosmetic & Implant Dentistry Center has dental implant solutions for you. To learn more, call (866) 223-6147, or go to algodonesdentalimplants.com ...
Dr. Jordan Heimer DMD, Head of Restorative for Nuvia Dental Implant Center, explains the Nuvia process and how it differs from the traditional dental implant processes that we are familiar with.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback